Shareholders' Equity and Share-based Payments [Text Block] | 5 . STOCKHOLDERS’ EQUITY Stock-based compensation is estimated at the grant date based on the award ’s fair value and is recognized on a straight-line basis over the vesting periods, generally four . Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Cost of design-to-silicon yield-solutions $ 1,184 $ 1,191 $ 3,445 $ 3,232 Research and development 877 894 2,558 2,251 Selling, general and administrative 888 892 2,734 2,452 Stock-based compensation expenses $ 2,949 $ 2,977 $ 8,737 $ 7,935 On September 30, 2017, Stock Plans — At the annual meeting of stockholders on November 16, 2011, 2011 “2011 2011 may 9,050,000 3,500,000 2001 2001 November 16, 2011. 1.33 no ten four In 2001, adopted a 2001 “2001 2003, 2001 2001Plan 2011. 2001 ten four no may 2001 2001 The Company estimated the fair value of share-based awards granted under the 2011 Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Expected life (in years) 4.41 4.42 4.41 4.42 Volatility 41.49 % 42.97 % 41.53 % 43.82 % Risk-free interest rate 1.65 % 1.10 % 1.69 % 1.20 % Expected dividend — — — — Weighted average fair value per share of options granted during the period $ 5.78 $ 5.52 $ 6.14 $ 4.82 As of September 30, 2017, 9.6 2011 3.9 2011 0.5 2001 2011 September 30, 2017. September 30, 2017, no 2011 2001 Stock option activity under the Company ’s Stock Plans during the nine September 30, 2017, Number of Options (in thousands) Weighted Average Exercise Price per Share Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Outstanding, January 1, 2017 1,364 $ 8.00 Granted (weighted average fair value of $6.1 4 per share) 100 $ 16.97 Exercised (366 ) $ 6.43 Canceled (16 ) $ 15.63 Expired (1 ) $ 18.10 Outstanding, September 30, 2017 1,081 $ 9.23 4.73 $ 7,133 Vested and expected to vest, September 30, 2017 1,065 $ 9.13 4.66 $ 7,124 Exercisable, September 30, 2017 893 $ 7.82 3.82 $ 6,966 The aggregate intrinsic value in the table above represents the total intrinsic value based on the Company ’s closing stock price of $15.49 September 30, 2017. nine September 30, 2017, $4.6 As of September 30, 2017, $1.0 3.3 nine September 30, 2017, $0.2 Nonvested restricted stock units activity during the nine September 30, 2017, Shares (in thousands) Weighted Average Grant Date Fair Value Per Share Nonvested, January 1, 2017 1,542 $ 15.50 Granted 793 $ 16.53 Vested (431 ) $ 15.78 Forfeited (99 ) $ 15.93 Nonvested, September 30, 2017 1,805 $ 15.86 As of September 30, 2017, $23.3 2.8 not Employee Stock Purchase Plan — In July 2001, ten 10% 85% twenty-four four six January 1 2002, 1 675,000 2 2% 3 May 18, 2010, May 17, 2020. The Company estimated the fair value of purchase rights granted under the Purchase Plan during the period using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions, resulting in the following weighted average fair values: Nine Months Ended September 30, 2017 2016 Expected life (in years) 1.25 1.25 Volatility 40.63 % 44.00 % Risk-free interest rate 1.25 % 0.50 % Expected dividend — — Weighted average fair value per share of options granted during the period $ 5.22 $ 3.70 During the three September 30, 2017 2016, 99,550 88,543 $9.53 $8.81 nine September 30, 2017 2016, 199,827 173,001 $9.33 $9.00 September 30, 2017, $0.5 1.24 September 30, 2017, 4.3 Stock Repurchase Program —On October 25, 2016, $25.0 two three nine September 30, 2017, 565,903 842,182 September 30, 2017, 842,182 $15.93 $13.4 $11.6 |